MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer

被引：0
|
作者：
Michael J. G. Milevskiy
Udai Gujral
Carolina Del Lama Marques
Andrew Stone
Korinne Northwood
Lez J. Burke
Julia M. W. Gee
Kenneth Nephew
Susan Clark
Melissa A. Brown
机构：
[1] University of Queensland,School of Chemistry and Molecular Biosciences
[2] Garvan Institute of Medical Research,Division of Genomics and Epigenetics, Epigenetics Research Laboratory
[3] The University of Queensland,UQ Centre for Clinical Research
[4] Cardiff University,School of Pharmacy and Pharmaceutical Sciences
[5] Indiana University,School of Medicine
[6] The Walter and Eliza Hall Institute of Medical Research,ACRF Stem Cells and Cancer
来源：
British Journal of Cancer | 2019年 / 120卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：621 / 632
页数：11
相关论文
共 50 条
  • [1] MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER plus breast cancer
    Milevskiy, Michael J. G.
    Gujral, Udai
    Marques, Carolina Del Lama
    Stone, Andrew
    Northwood, Korinne
    Burke, Lez J.
    Gee, Julia M. W.
    Nephew, Kenneth
    Clark, Susan
    Brown, Melissa A.
    BRITISH JOURNAL OF CANCER, 2019, 120 (06) : 621 - 632
  • [2] The diagnostic and prognostic values of microRNA-196a in cancer
    Xiong, Mengqiu
    Wang, Ping
    Pan, Bei
    Nie, Junjie
    Wang, Shukui
    He, Bangshun
    BIOSCIENCE REPORTS, 2021, 41 (01)
  • [3] MicroRNA-196a Is a Putative Diagnostic Biomarker and Therapeutic Target for Laryngeal Cancer
    Saito, Koichiro
    Inagaki, Koji
    Kamimoto, Takahiro
    Ito, Yoko
    Sugita, Toshiaki
    Nakajo, Satoko
    Hirasawa, Akira
    Iwamaru, Arifumi
    Ishikura, Takashi
    Hanaoka, Hideki
    Okubo, Keisuke
    Onozaki, Tokio
    Zama, Takeru
    PLOS ONE, 2013, 8 (08):
  • [4] Prognostic significance of ER-to-PR difference in ER+/HER2-early breast cancer
    Wu, Xiaoyan
    Zhang, Wenchuan
    Lu, Xunxi
    Zhong, Xiaorong
    Bu, Hong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Hippo signalling maintains ER expression and ER+ breast cancer growth
    Ma, Shenghong
    Wu, Zhengming
    Yang, Feng
    Zhang, Jianmin
    Johnson, Randy L.
    Rosenfeld, Michael G.
    Guan, Kun-Liang
    NATURE, 2021, 591 (7848) : E1 - E10
  • [6] Hippo signalling maintains ER expression and ER+ breast cancer growth
    Shenghong Ma
    Zhengming Wu
    Feng Yang
    Jianmin Zhang
    Randy L. Johnson
    Michael G. Rosenfeld
    Kun-Liang Guan
    Nature, 2021, 591 : E1 - E10
  • [7] EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer
    Jing Pan
    Xing-Hua Han
    Wei Wang
    Yue-Yin Pan
    Asian Pacific Journal of Tropical Medicine, 2018, 11 (04) : 297 - 304
  • [8] Estetrol for treatment of advanced ER+ breast cancer
    Verhoeven, Carole
    Schmidt, Marcus
    Hoenig, Arnd
    Duennebacke, Jan
    Dutman, Ellen
    Krijgh, Jan
    Bennink, Herjan Coelingh
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Estetrol for treatment of advanced ER+ breast cancer
    Schmidt, M.
    Honig, A.
    Verhoeven, C.
    Almstedt, K.
    Battista, M.
    Lenhard, H. G.
    Krijgh, J.
    Bennink, H. Coelingh
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Modeling ER+ breast cancer dormancy in mice
    Alexandra Le Bras
    Lab Animal, 2022, 51 : 285 - 285
12345